A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naive patients with chronic hepatitis C
- 1 September 2003
- journal article
- clinical trial
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 10 (5) , 383-389
- https://doi.org/10.1046/j.1365-2893.2003.00439.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cost effectiveness of combination therapy for hepatitis C: a decision analytic modelGut, 2002
- Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trialsBMJ, 2001
- Combination of interferon induction therapy and ribavirin in chronic hepatitis CHepatology, 2001
- Interferon and amantadine in combination as initial treatment for chronic hepatitis C patientsJournal of Hepatology, 2001
- Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experienceJournal of Hepatology, 2000
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Morphological study of vascular dissemination in a metastatic hepatocellular carcinoma model in the monkeyHepatology, 1997
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and durationHepatology, 1996